Blockchain Registration Transaction Record

Lisata Therapeutics CEO Encouraged by Progress on Pancreatic Cancer Trial

Lisata Therapeutics CEO discusses completion of patient enrollment for pancreatic cancer trial in Phase 1B/2A CENDIFOX trial

Lisata Therapeutics CEO Encouraged by Progress on Pancreatic Cancer Trial

The completion of patient enrollment for the pancreatic cancer cohorts in Lisata Therapeutics' Phase 1B/2A CENDIFOX trial marks a significant milestone in the evaluation of certepetide's safety and efficacy. This progress brings hope to patients with pancreatic, colon, and appendiceal cancers, and the collection of pre- and post-treatment biopsies could lead to valuable insights for future treatments.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x5d07924bd543f28eee9b2a49c933034bca0110007132405475685bda6916719a
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintevenBbFJ-40241a885f01c99bec257692a9feda74